Medication info
Atorvastatin/Ezetimibe Tablet 10/10 mg

Atorvastatin/Ezetimibe Tablet 10/10 mg

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tabletAtorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
White or whitish film-coated tablet in an elongated shape
Packaging
30 tablets/box [10 tablets/Alu-Alu x 3]
Approval status
Active

MFDS item code 202101521 · Approved 2021.02.18 · Insurance code 647303990

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who uses it
Adults
Adult dosage
This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), an initial dose of 10/40mg once daily is recommended. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps reduce total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol. It is particularly used as an adjunct when other lipid-lowering therapies are insufficient in patients with homozygous familial hypercholesterolemia. This drug should be administered alongside dietary therapy for dyslipidemia, considering various risk factors of the patient for appropriate usage. Additionally, it is important to check if there are other diseases or conditions causing dyslipidemia and to undertake necessary treatments. Therefore, this drug is effectively used for the treatment of hypercholesterolemia and related dyslipidemia.

Dosage and Administration

Adult dosage

This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), an initial dose of 10/40mg once daily is recommended. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.

Precautions

This medication may lead to serious muscle problems; therefore, if symptoms such as sudden muscle pain, muscle weakness, or high fever occur, inform a doctor immediately. Patients at risk for renal function impairment due to severe infections, hypotension, major surgery, trauma, or severe metabolic abnormalities should temporarily discontinue or stop taking this medication. Patients with allergies to this drug's components, severely impaired liver function, muscle disorders, pregnant women, or nursing mothers should not take this drug. Additionally, patients on certain antiviral medications or with lactose intolerance should also avoid this medication. Patients with alcohol dependence or a history of liver disease, impaired renal function, hypothyroidism, or a family history of muscle disorder, as well as those over 70 years of age, should use this drug with caution. Careful monitoring is needed when taken in conjunction with fibrate-class drugs due to increased risk of muscle issues. During treatment with this medication, side effects such as liver function abnormalities, muscle pain, abdominal pain, and dizziness may occur; if symptoms worsen, consult a doctor. Liver enzyme levels should be regularly monitored, and if signs of liver damage appear, use should be discontinued. Women who are pregnant or planning to become pregnant should not use this medication and should use appropriate contraception while on it. Dizziness may occur, so caution is necessary when driving or operating machinery. This medication has many drug interactions, so if other medications are being taken, it is essential to inform a doctor or pharmacist, and dose adjustments may be required when taken with drugs affecting liver metabolism. In the case of overdose, treatment should be based on symptoms, and liver function and muscle condition should be monitored. This medication has not established safety and efficacy in children, so it is not recommended for use. No specific dose adjustment is needed for elderly patients, but careful observation is required due to an increased risk of muscle problems. Patients with active liver disease or persistent unexplained elevations in liver enzymes should not take this drug. Patients with impaired renal function should be regularly checked for the risk of muscle issues. Symptoms such as muscle pain, fatigue, or fever during treatment with this drug should be reported to healthcare personnel immediately, and blood tests may be necessary to check for muscle damage.

Side effects

Acute kidney failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, increased liver enzymes, ALT increase, AST increase, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast masses, skin masses, thyroid adenoma, weakness, fatigue, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal distension, dyspepsia, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleeds, insomnia, nightmares, headache, paresthesia, sensory loss, dysgeusia, memory loss, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications from ruptures, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, urinary tract infection, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, chromaturia, hypoglycemia, appetite stimulation, vasogenic edema, chest pain, angina, facial edema, fever, neck stiffness, generalized edema, amblyopia, dry eye, refractive errors, retinal hemorrhage, glaucoma, cheirospasm, dysgeusia, leukopenia, decreased testosterone, increased cholinesterase, elevated TSH, elevated ACTH, decreased aldosterone, cerebral infarction, palpitations, tachycardia, diabetic neuropathy, tremors, epigastric pain, gastritis, epigastric discomfort, gastrointestinal disorders, gastroesophageal reflux disease, tongue diseases, heart palpitations, congestive heart failure, myocardial ischemia, sputum, runny nose, limb pain, diaphoresis, conjunctival injection, renal failure, abnormal liver function, increased blood creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to keep it away from air and moisture. It is best to store it between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White or whitish film-coated tablet in an elongated shape

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.